
Organometallics p. 3958 - 3962 (1995)
Update date:2022-07-30
Topics: Characterization Isolation and Purification Preparation of the starting material
Liu, Ling-Kang
Eke, Uche B.
Adediran Mesubi
One equivalent of NaOMe is added to an equimolar mixture of (η-C5H5)Fe(CO)2I (1) and PPh3 after the addition of a few drops of n-BuLi, to take advantage of the catalytic formation of [(η5-C5H5)Fe(CO)2(PPh) 3]+I- (3), which, upon formation, becomes the virtual reactant with OMe-. The OMe- reaction yields the methyl carboxylate (η5-C5H5)Fe(CO)(PPh)3C(O)OMe (8Me). A similar pattern is observed in the OPh-, SMe-, and SPh- reactions, resulting in the derivatives (η5-C5H5)Fe(CO)(PPh)3C(O)OPh (8Ph), (η5-C5H5)Fe(CO)(PPh)3C(O)SMe (9Me), and (η5-C5H5)Fe(CO)(PPh)3C(O)SPh (9Ph), respectively. The metalloesters exist simultaneously in the molecular form (8R) and the ionic form [(η5-C5H5)Fe(CO)2(PPh) 3]+ OR- (10R; R = Me, Ph) in solutions of medium polarity (CHCl3, CH2Cl2, and MeCN), whereas the S analogs exist only in the ionic form. In CHCl3, CH2Cl2, and MeCN solutions, the ratio of neutral 8Me to ionic 10Me is ca. (6.0-8.4):1, as judged from the NMR measurements. Nonetheless, the ratio of neutral 8Ph to ionic 10Ph is ca. (0.17-0.25):1.
Jingzhou TianHe Sci&Tech Chemical Co., Ltd.
Contact:86-716-8331612
Address:Jiangjin Road, #18, High-grade technology industries development district, Jingzhou city, Hubei province
Yueyang Hudex Pharmaceuticals Ltd.
Contact:0730-8748800
Address:Wujiang Bridge,Yueyang Economy & Technology Development Zone
Lishui Nanming Chemical Co., Ltd(expird)
Contact:+86-0578-2134101,2697830
Address:No.19 Tongji Road Shuige Industrial zone
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Daqing New Century Fine Chemical Co., Ltd.(expird)
Contact:010-57126694
Address:No.39, jinxing cun, honggang district
Doi:10.1016/0040-4039(94)85340-1
(1994)Doi:10.1080/15257779508012498
(1995)Doi:10.1080/00397919508011814
(1995)Doi:10.1021/acschemneuro.8b00196
(2019)Doi:10.1021/j150666a041
(1984)Doi:10.1016/0008-6215(94)00004-Y
(1995)